Dear Reader,


Multiple myeloma (MM) is a malignancy of plasma cells characterised by a monoclonal proliferation of plasma cells resulting in the production of monoclonal antibodies and end-organ damage. Notably, MM has been classified as one of the most difficult cancers to diagnose and diagnostic delays are common. Although the advancement in new therapeutics in recent decades has significantly improved the survival of MM patients, the disease is generally considered incurable and a substantial proportion of patients would develop relapsed and refractory MM (RRMM). Thus, the treatment of MM is a long journey with significant physiological, psychosocial and economic burdens for the patients. In order to have a closer look at the clinical difficulties in managing MM and the disease burden faced by the patients, Dr. Li Wa, Specialist in Haematology & Haematological Oncology, was invited to share his opinions on the holistic care for patients with MM.


Besides MM, recent development in pharmacologic optimisation on perioperative care for elderly patients will be featured in the Industry Updates. On the other hand, the renal safety profile of chronic hepatitis B treatment and the physiological implications of lucid dreaming are discussed in the Epoch section.


The core objective of V·Pulse is to provide local medical practitioners with an update on medical breakthroughs. In order to match better with the broad spectrum of our readers' interests, we are pleased to introduce the new thematic section, "Focus", which covers selected medical issues with local social impact. For the first issue of Focus section, Dr. Wong Tin Yau Andrew was invited to share his experiences and opinions on clinical care for people living with HIV (PLWH) in the current COVID-19 pandemic.

Hope you enjoy this issue!


Best wishes, stay safe and healthy!


Dr. Roy Yuen-chi Lau





In order to provide articles better matched with your interest, a V∙Pulse Reader Survey has been launched to collect your opinions on the preferred topics. Please provide your opinions by completing the online questionnaire in the link here.